Stock Information
Roivant Sciences Ltd (ROIV)
Ticker Symbol: ROIV
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $20,127.53 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -1.1684
Revenue (TTM): $0.02 M
Dividend Yield: N/A%
ROE: -18.32%
Latest News
-
Spyre: 'Strong Buy' As UC Program Moves Along And Q3 2026 RA Data Looms
Tue, Mar 17, 2026 2:18 PM
-
Roivant Sciences Ltd. (ROIV) Discusses $2.25 Billion Global Settlement Resolving COVID Vaccine Patent Litigation - Slideshow
Fri, Mar 13, 2026 7:07 PM
-
Roivant Sciences Ltd. (ROIV) Presents at Leerink Global Healthcare Conference 2026 Transcript
Wed, Mar 11, 2026 2:12 PM
Key Financials
Financial data not available
